CV Sciences, Inc.
CVSI
$0.03
$0.00051.70%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.46% | -1.87% | -2.80% | 0.71% | -0.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.46% | -1.87% | -2.80% | 0.71% | -0.30% |
| Cost of Revenue | -4.21% | -4.28% | -8.49% | -6.17% | -10.57% |
| Gross Profit | -2.56% | 1.17% | 4.75% | 10.18% | 15.87% |
| SG&A Expenses | -14.31% | -8.45% | -6.10% | -10.32% | -13.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Operating Expenses | -12.46% | 41.17% | 38.75% | 35.01% | 24.14% |
| Operating Income | 70.21% | -134.95% | -143.79% | -166.34% | -316.56% |
| Income Before Tax | 41.77% | -177.58% | -467.05% | -2,443.52% | -156.92% |
| Income Tax Expenses | -- | -33.33% | 93.48% | 93.48% | 100.00% |
| Earnings from Continuing Operations | 41.99% | -177.18% | -443.77% | -1,741.56% | -166.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.99% | -177.18% | -443.77% | -1,741.56% | -166.89% |
| EBIT | 70.21% | -134.95% | -143.79% | -166.34% | -316.56% |
| EBITDA | 82.84% | -124.92% | -133.90% | -151.95% | -233.25% |
| EPS Basic | 50.00% | -166.50% | -420.83% | -2,357.14% | -20.23% |
| Normalized Basic EPS | 64.49% | -137.75% | -150.39% | -193.33% | -1,428.57% |
| EPS Diluted | 50.24% | -166.83% | -422.92% | -2,371.43% | 0.00% |
| Normalized Diluted EPS | 64.49% | -137.75% | -150.39% | -193.33% | -1,428.57% |
| Average Basic Shares Outstanding | 15.40% | 14.01% | 10.44% | 7.33% | 7.10% |
| Average Diluted Shares Outstanding | 15.40% | 14.01% | 10.44% | 7.33% | 7.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |